Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03029546 · ClinicalTrials.gov registry record
Effect of Glucose Load on Expression of Advanced Glycation End Products in Women Screened for Gestational Diabetes
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 105
- Enrollment target
NCT03029546 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 105 participants.
The verdict
NCT03029546 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 105 participants
- Enrollment target
Study Summary
The investigator's main objective is to analyze the effects of a routine prenatal care screening tool (glucola test for gestational diabetes) on maternal inflammation through assessment of maternal circulatory biomarkers and blood pressure. Improving knowledge about routine prenatal care and how a variety of screening factors affect maternal physiology allows the investigators to be educated and informed when caring for mothers with medical co-morbidities. * Determine if an acute glucose load (50g) is associated with an in-vivo and in-vitro increase in the concentration of Advanced Glycation End Products (AGEP's) that, in turn, can impact vascular endothelial reactivity and induce an acute increase in blood pressure. Previous studies generated in the investigators' laboratory showed that circulating soluble Receptor for Advanced Glycation End Products (sRAGE) and Tumor Necrosis Factor (TNF)-a (mediator of acute inflammation) are considered markers of the extent of maternal RAGE activation and/or systemic inflammation, respectively. * Determine how an acute glucose load (50g) at the time of normal screening for gestational diabetes induces an acute increase in the level of sRAGE and TNF-a. If the investigators' hypothesis is confirmed, the investigators will have strong confirmation of the involvement of glycation products and TNF-a in generating the acute negative clinical symptoms of women experiencing a glucose tolerance test, such as headache, nausea, sweating, and bloating.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03029546
The ClinicalTrials.gov registry entry for NCT03029546 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03029546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03029546 about?
NCT03029546 is a clinical study titled "Effect of Glucose Load on Expression of Advanced Glycation End Products in Women Screened for Gestational Diabetes". The investigator's main objective is to analyze the effects of a routine prenatal care screening tool (glucola test for gestational diabetes) on maternal inflammation through assessment of maternal circulatory biomarkers and blood pressure. Improving knowledge about routine prenatal care and how a v...
What is the current status of trial NCT03029546?
This trial is currently completed. The enrollment target is 105 participants. The study started on 2015-11. Estimated completion is 2019-11.
Who is sponsoring clinical trial NCT03029546?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.